8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... visualabstract #table
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ACEI indicates angiotensin-converting ... angiotensin-receptor blocker; CAD ... heart failure; HFpEF ... ejection fraction; HFrEF ... Stages #ACCAHA #Algorithm
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
exacerbation ACEl ... Valsartan • AKI ... Amlodipine • HFrEF ... Spironolactone • AKI ... #pharmacology #table
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
and CKD • Class ... I pillars of HFrEF ... kidney disease: ACEI ... been optimized: IKi ... Therapy #GDMT #CKD
Acute Kidney Injury - AKI Workup Algorithm and Differential Diagnosis
Baseline Investigations: full blood count with differential,
Kidney Injury - AKI ... Workup Algorithm ... ANCA, ANA, Anti-GBM ... Kidney #Injury #AKI ... #Workup #Algorithm
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... Algorithm 1. ... ARB: if ACE inhibitor ... controlled by ACE ... #Algorithm #cardiology
HSCT related renal disease - AKI and CKD
Acute Kidney Injury: Acute GvHD 2-4, Pre renal state,
renal disease - AKI ... and CKD Acute ... Acyclovir, Amp B, ACE ... renal #disease #AKI ... differential #diagnosis #algorithm
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Medications: K+, ACEi ... , RTA Type IV, AI ... VBG (acidosis), CK ... Elimination (see Table